128 related articles for article (PubMed ID: 36308485)
1. Effectiveness of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with brain metastases from renal cell carcinoma: inverse probability of treatment weighting using propensity scores.
Yomo S; Oda K; Oguchi K
J Neurosurg; 2023 Jun; 138(6):1591-1599. PubMed ID: 36308485
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis.
Yomo S; Oda K; Oguchi K
J Neurosurg; 2023 Dec; 139(6):1628-1637. PubMed ID: 37243558
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study.
Shepard MJ; Xu Z; Donahue J; Eluvathingal Muttikkal TJ; Cordeiro D; Hansen L; Mohammed N; Gentzler RD; Larner J; Fadul CE; Sheehan JP
J Neurosurg; 2019 Jul; 133(3):685-692. PubMed ID: 31349225
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery with immune checkpoint inhibitors for brain metastases: a meta-analysis study.
Badrigilan S; Meola A; Chang SD; Rezaeian S; Nemati H; Almasi T; Rostampour N
Br J Neurosurg; 2023 Dec; 37(6):1533-1543. PubMed ID: 34979828
[TBL] [Abstract][Full Text] [Related]
6. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
[TBL] [Abstract][Full Text] [Related]
7. Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases.
Koenig JL; Shi S; Sborov K; Gensheimer MF; Li G; Nagpal S; Chang SD; Gibbs IC; Soltys SG; Pollom EL
World Neurosurg; 2019 Jun; 126():e1399-e1411. PubMed ID: 30902777
[TBL] [Abstract][Full Text] [Related]
8. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
9. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone.
Dohm AE; Tang JD; Mills MN; Liveringhouse CL; Sandoval ML; Perez BA; Robinson TJ; Creelan BC; Gray JE; Etame AB; Vogelbaum MA; Forsyth P; Yu HM; Oliver DE; Ahmed KA
J Neurosurg; 2023 Jun; 138(6):1600-1607. PubMed ID: 36681988
[TBL] [Abstract][Full Text] [Related]
12. Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery.
Stenman M; Benmakhlouf H; Wersäll P; Johnstone P; Hatiboglu MA; Mayer-da-Silva J; Harmenberg U; Lindskog M; Sinclair G
Acta Neurochir (Wien); 2021 Feb; 163(2):333-342. PubMed ID: 32902689
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry.
Michalopoulos GD; Katsos K; Grills IS; Warnick RE; McInerney J; Attia A; Timmerman R; Chang E; Andrews DW; D'Ambrosio AL; Cobb WS; Pouratian N; Spalding AC; Walter K; Jensen RL; Bydon M; Asher AL; Sheehan JP
J Neurosurg; 2024 May; 140(5):1223-1232. PubMed ID: 37948684
[TBL] [Abstract][Full Text] [Related]
14. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract][Full Text] [Related]
16. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.
Carpenter DJ; Leng J; Arshad M; Giles W; Kirkpatrick JP; Floyd SR; Chmura SJ; Salama JK; Hong JC
JAMA Netw Open; 2023 Apr; 6(4):e2310117. PubMed ID: 37099292
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
[No Abstract] [Full Text] [Related]
18. Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study.
Lehrer EJ; Gurewitz J; Bernstein K; Patel D; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Malouff TD; Ruiz-Garcia H; Patel S; Bonney PA; Hwang L; Yu C; Zada G; Mathieu D; Trudel C; Prasad RN; Palmer JD; Jones BM; Sharma S; Fakhoury KR; Rusthoven CG; Deibert CP; Picozzi P; Franzini A; Attuati L; Lee CC; Yang HC; Ahluwalia MS; Sheehan JP; Trifiletti DM
Cancer; 2022 Apr; 128(7):1429-1438. PubMed ID: 35077586
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
[TBL] [Abstract][Full Text] [Related]
20. The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI).
Yomo S; Serizawa T; Yamamoto M; Higuchi Y; Sato Y; Shuto T; Akabane A; Jokura H; Kawagishi J; Aoyama H
J Neurooncol; 2019 Oct; 145(1):151-157. PubMed ID: 31487030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
